Global /Taiwan /Healthcare /Medical Distribution /6621

UniPharma Co., Ltd.

6621

• TPEX: 6621 • Delayed

13.15TWD 0.4%

0.4161 USD

As of 12 June 2026, UniPharma Co., Ltd. has a market cap of $14.73M USD, ranking #39107 globally and #2291 in Taiwan. It ranks #3488 in the Healthcare sector, and #166 in the Medical Distribution industry.

Global Rank

39107

Country Rank

2291

Sector Rank

3488

Industry Rank

166

Key Stats

Market Cap

$14.73MUSD

465.06M TWD

Enterprise Value

$10.78MUSD

340.67M TWD

Revenue (TTM)

$2.8MUSD

88.44M TWD

EBITDA (TTM)

-$1.29MUSD

-40.89M TWD

Net Income (TTM)

-$1.28MUSD

-40.54M TWD

EBITDA Margin

-46%

Profit Margin

-46%

PS Ratio

5.3

PB Ratio

2.0

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Distribution

CEO

Yu-Shan Wang open_in_new

Employees

Founded

1998

Website

uni-pharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.4%	-3.7%	-3%	-7.2%	7.1%	5.8%	-17%	-36%	-2.3%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6621 華宇藥品股份有限公司 ISIN: TW0006621006 Shares Out.: Shares Outstanding: 35.501M¹ TV: TradingView: TPEX: 6621 SA: Stock Analysis: TPEX: 6621 YF: Yahoo Finance: 6621.TWO GF: Google Finance: TPEX: 6621 BA: Barron's: 6621 MS: Morningstar: ROCO: 6621	13.15 TWD	TV: TradingView: TPEX: 6621 SA: Stock Analysis: TPEX: 6621 YF: Yahoo Finance: 6621.TWO GF: Google Finance: TPEX: 6621 BA: Barron's: 6621 MS: Morningstar: ROCO: 6621

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About UniPharma Co., Ltd.

UniPharma Co., Ltd. engages in the distribution of pharmaceutical drugs, medical devices, and diagnostic tests in Taiwan. It provides diagnostic tests in areas of oncology, gynecology, orthopedics, neurology, anesthesiology, and cardiology. The company offers Adept reduction solution; bain, esmolol HCI, and naloxone anesthesia injections; Elisa DR-70 test for in-vitro diagnostics of tumors; and fomeject antidote injection, as well as drug development, research and development, clinical trials, marketing, and other business services. It serves medical centers, regional and area hospitals, and clinics. UniPharma Co., Ltd. was founded in 1998 and is based in Taipei, Taiwan.

Similar Companies

Industry: Medical Distribution (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Excelsior Medical Co., Ltd. TWSE: 4104	$387.89M 12.25B TWD 3K%	15.3	Taiwan
Gongwin Biopharm Holdings Co., Ltd. TPEX: 6617	$292.76M 9.25B TWD 2K%	-	Taiwan
CHC Healthcare Group TWSE: 4164	$182.13M 5.75B TWD 1K%	29.5	Taiwan
WeLeader Biomedical Co., Ltd. TPEX: 7713	$97.2M 3.07B TWD 560%	14.9	Taiwan
ShareHope Medicine Co., Ltd. TPEX: 8403	$93.92M 2.97B TWD 538%	20.9	Taiwan
Eyecare Tech Inc. TPEX: 7881	$82.07M 2.59B TWD 457%	-	Taiwan

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 684K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 411K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 324K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 57K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 51K%	7.2	China
Galenica AG SIX: GALE	$5.26B 4.2B CHF 36K%	23.0	Switzerland

chevron_leftBack